Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release

By Rajagopalan Krithika  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 987-996

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data

By Rajagopalan Krithika  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 951-961

Informa Healthcare

Access to resources Recommend Favorite

New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 6, 2015-06 ,pp. : 854-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tobacco use key risk factor in premature deaths for adults with schizophrenia

By  

MENTAL HEALTH WEEKLY, Vol. 25, Iss. 43, 2015-11 ,pp. : 1-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves new drug to treat schizophrenia, MDD

By  

MENTAL HEALTH WEEKLY, Vol. 25, Iss. 28, 2015-07 ,pp. : 6-6

John Wiley & Sons Inc

Access to resources Recommend Favorite